Clear Street Launches Healthcare & Biotechnology Equity Research

BusinesswireDec 17 14:00 ET

We're Hopeful That Enliven Therapeutics (NASDAQ:ELVN) Will Use Its Cash Wisely

Simply Wall StDec 14 09:13 ET

BTIG Initiates Enliven Therapeutics(ELVN.US) With Buy Rating, Announces Target Price $42

Moomoo NewsDec 13 06:31 ET · Ratings

Enliven Therapeutics' ELVN-001: Navigating Competitive Challenges and Opportunities in the CML Market

TipRanksDec 10 13:55 ET

LifeSci Capital Maintains Enliven Therapeutics(ELVN.US) With Buy Rating, Maintains Target Price $38

Moomoo NewsDec 9 08:31 ET · Ratings

JonesTrading Maintains Enliven Therapeutics(ELVN.US) With Buy Rating, Maintains Target Price $36

Moomoo NewsDec 5 11:35 ET · Ratings